Skip to content
★ Sign in to follow
HT

High Tech Pharm Co., Ltd. Stock: price and insider trades · South Korea

하이텍팜

KR·Mcap ₩93.7BHealth Care

1 insider bought €1,056 of shares over the last 90 days, the latest by 차현준, filed 12 Aug 2026.

Insider Decl.
16
Thresholds
n/a
Buy Volume
€143,878
8 ops. · all time
Sell Volume
€3M
4 ops. · all time

Who traded when

BuySale
Acsdobfars.P.A1 buy1 sale
강신준1 buy1 sale
박진용2 buys
차현준2 buys
이승주1 buy

Since the insiders bought

  • Filed 30 Mar 2026 · 223 days ago · €41k
    -60.1%
    Entry ₩21,700 · Close 30 Oct 2026 ₩8,650
  • Filed 27 Mar 2026 · 226 days ago · €224
    -61.2%
    Entry ₩22,300 · Close 30 Oct 2026 ₩8,650
  • Filed 27 Mar 2026 · 226 days ago · €2,676
    -61.2%
    Entry ₩22,300 · Close 30 Oct 2026 ₩8,650

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Fundamental score
Ranked 1,232 of 26,897 companies
79.5
score / 100
Value
90
Quality
70
FCF yld16%
Earn yld12%
EV/EBITDA4.8x
ROE9.3%
Gross mgn24%
Net mgn16%
Debt/EBITDA0.0x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

₩8,810
Analyst consensus
·
Income statement
Revenue₩70.2B
Gross profit₩16.9B24% margin
EBITDA₩19.4B28% margin
Net income₩11.5B17.2% margin
Valuation
Beta0.04
Balance sheet & cash
Market cap₩93.7B
Total debt₩33.6M
Free Cash Flow₩15.1B
Debt / Equity0%
Profitability & ownership
ROE9.3%
ROA5.3%
% insiders45.2%
% institutions0.3%
Last declaration on 12 August 2026
Declarations17 total
  • ▼
    사외이사Executives(filed)
    €15kest.0DART
    2,133 sharesShareKRXDART:20260812000689
  • Other
    Other(filed)
    0DART
  • ▲
    사내이사Executives(filed)
    €1,056est.0DART
    152 sharesShareKRXDART:20260812000694
    Canonical exit: 10 Nov 2026 (T+90)
  • ▼
    Executives
    €2.5Mest.0DART
    200,000 sharesKRXDART:20260331004193
  • ▲
    Executives
    €41kest.0DART
    3,159 sharesKRXDART:20260330001084
    Canonical exit: 25 Jun 2026 (T+90)
  • ▲
    사외이사Executives
    €224est.0DART
    20 sharesShareKRXDART:20260327000949
    Canonical exit: 18 Jun 2026 (T+90)
  • ▲
    사내이사Executives
    €2,676est.0DART
    239 sharesShareKRXDART:20260327000826
    Canonical exit: 18 Jun 2026 (T+90)
  • ▲
    사외이사Executives
    €90kest.0DART
    8,000 sharesShareKRXDART:20260327000906
    Canonical exit: 18 Jun 2026 (T+90)
  • ●
    Executives
    Executives(filed)
    0DART
  • ▲
    상무이사Executives(filed)
    €6,523est.0DART
    900 sharesShareKRXDART:20251203000084
    Canonical exit: 3 Mar 2026 (T+90)
  • ▲
    상무이사Executives(filed)
    €3,309est.0DART
    420 sharesShareKRXDART:20250526000209
    Canonical exit: 24 Aug 2025 (T+90)
  • ●
    Executives
    Executives(filed)
    0DART
  • ▼
    Executives(filed)
    €248kest.0DART
    49,300 sharesKRXDART:20220721000224
  • ▼
    Executives(filed)
    €378kest.0DART
    49,300 sharesKRXDART:20210528000985
  • ▲
    상무이사Executives(filed)
    0DART
    ShareKRXDART:20210528000992
    Canonical exit: 26 Aug 2021 (T+90)
  • ●
    Executives
    Executives(filed)
    0DART
  • ●
    Executives
    Executives(filed)
    0DART

17 of 17 declarations

About High Tech Pharm Co., Ltd.

Four insiders bought between March 20 and March 27, 2026 at 하이텍팜 (High Tech Pharm Co., Ltd.), and the 2026 trades stop on March 30. That cluster of trades carries most of the 16 filings of the South Korean health care company, valued at KRW 98.9 billion and 45.2% held by its insiders.

The record has 8 purchases and 4 sales, and 4 filings of another kind. No amount is reported. Acsdobfars.P.A filed 5, with 1 purchase and 3 sales. 박진용 (상무이사) counts 3 purchases, 차현준 (사내이사) 2 purchases, and 강신준 (사외이사) 1 purchase and 1 sale. The company 하이텍팜 signs 2 filings itself.

Read moreShow less

Filings were published from February 26, 2021 to August 12, 2026: 4 in 2021, 1 in 2022, 1 in 2023, 2 in 2025 and 8 in 2026. The 9 filings of the last twelve months comprise 6 purchases and 2 sales. The publication delay is 7 days at the median, across 5 measured.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations